Background:
A biotechnology company manufacturing custom media for pharmaceutical purposes faced a shortage of Cholesterol due to high demand from COVID vaccine production.
Challenge:
The customer's cell culture applications required a steady supply of Cholesterol, but the market lacked sufficient product. The limited production capacity hindered their ability to keep up with the growing demand from the cell culture industry.
Solution:
To address the challenge, we leveraged our existing resources to manufacture Cholesterol, refining the manufacturing processes to meet USP/EP requirements and reduce trace metal contamination. We were able to provide the customer with a reliable supply of Cholesterol that met their needs and allowed for future growth.
Result:
The customer received a high-quality Cholesterol product that met their specifications, enabling them to meet the demands of the cell culture industry and support their ongoing pharmaceutical manufacturing endeavors.